Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...
Discover Merck's groundbreaking patent on genetic markers linked to enhanced C. difficile treatment responses. Learn how personalized therapy can improve patient outcomes.
A C-reactive protein test (CRP) is a blood test that detects general inflammation in ... A test called a high-sensitivity CRP (hs-CRP) test can be used in people with risk factors for heart disease to ...
Joyce Beatty (D-OH) on cancer research and treatment Javascript must be enabled in order to access C-SPAN videos. *This text was compiled from uncorrected Closed Captioning.
The stigma linking HIV to the LGBTQ+ community led to poor funding for treatment and unfair treatment ... along with viral infections such as hepatitis C and COVID-19. They block protease, an ...
diff., a bacterium that can cause serious infections in the colon. Symptoms can range from mild diarrhea and stomach pain to significant colon damage, which can sometimes require surgery. “Antibiotics ...